|
1
|
Parkin DM and Bray F: Chapter 2: The
burden of HPV-related cancers. Vaccine. 24 Suppl 3:S3/11–25. 2006.
View Article : Google Scholar
|
|
2
|
Shah KV, Kessis TD, Shah F, Gupta JW,
Shibata D and Jones RW: Human papillomavirus investigation of
patients with cervical intraepithelial neoplasia 3, some of whom
progressed to invasive cancer. Int J Gynecol Pathol. 15:127–130.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perez-Plasencia C, Duenas-Gonzalez A and
Alatorre-Tavera B: Second hit in cervical carcinogenesis process:
Involvement of wnt/beta catenin pathway. Int Arch Med. 1:102008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lustig B and Behrens J: The Wnt signaling
pathway and its role in tumor development. J Cancer Res Clin Oncol.
129:199–221. 2003.PubMed/NCBI
|
|
6
|
Kwong KY, Zou Y, Day CP and Hung MC: The
suppression of colon cancer cell growth in nude mice by targeting
beta-catenin/TCF pathway. Oncogene. 21:8340–8346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chien AJ, Moore EC, Lonsdorf AS,
Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL
and Moon RT: Activated Wnt/beta-catenin signaling in melanoma is
associated with decreased proliferation in patient tumors and a
murine melanoma model. Proc Natl Acad Sci USA. 106:pp. 1193–1198.
2009; View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Uren A, Fallen S, Yuan H, Usubütün A,
Küçükali T, Schlegel R and Toretsky JA: Activation of the canonical
Wnt pathway during genital keratinocyte transformation: A model for
cervical cancer progression. Cancer Res. 65:6199–6206. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pollack AL, Barth AI, Altschuler Y, Nelson
WJ and Mostov KE: Dynamics of beta-catenin interactions with APC
protein regulate epithelial tubulogenesis. J Cell Biol.
137:1651–1662. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takemaru KI and Moon RT: The
transcriptional coactivator CBP interacts with beta-catenin to
activate gene expression. J Cell Biol. 149:249–254. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calvisi DF, Ladu S, Factor VM and
Thorgeirsson SS: Activation of beta-catenin provides proliferative
and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis
promoted by phenobarbital. Carcinogenesis. 25:901–908. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
14
|
Yang JZ, Zhang XH, Wu WX, Yan X, Liu YL,
Wang JL and Wang FR: Expression of EP-CAM, beta-catenin in the
carcinogenesis of squamous cell carcinoma of uterine cervix.
Zhonghua Zhong Liu Za Zhi. 25:372–375. 2003.(In Chinese).
PubMed/NCBI
|
|
15
|
Saito-Diaz K, Chen TW, Wang X, Thorne CA,
Wallace HA, Page-McCaw A and Lee E: The way Wnt works: Components
and mechanism. Growth Factors. 31:1–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zirn B, Wittmann S, Graf N and Gessler M:
Chibby, a novel antagonist of the Wnt pathway, is not involved in
Wilms tumor development. Cancer Lett. 220:115–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li FQ, Mofunanya A, Harris K and Takemaru
K: Chibby cooperates with 14-3-3 to regulate beta-catenin
subcellular distribution and signaling activity. J Cell Biol.
181:1141–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li FQ, Mofunanya A, Fischer V, Hall J and
Takemaru K: Nuclear-cytoplasmic shuttling of Chibby controls
beta-catenin signaling. Mol Biol Cell. 21:311–322. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vandepoele K, Staes K, Andries V and van
Roy F: Chibby interacts with NBPF1 and clusterin, two candidate
tumor suppressors linked to neuroblastoma. Exp Cell Res.
316:1225–1233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu HT, Li QC, Dai SD, Xie XM, Liu DI and
Wang EH: The expression patterns and correlations of chibby,
β-catenin and DNA methyltransferase-1 and their clinicopathological
significance in lung cancers. APMIS. 119:750–758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karakoula K, Suarez-Merino B, Ward S,
Phipps KP, Harkness W, Hayward R, Thompson D, Jacques TS, Harding
B, Beck J, et al: Real-time quantitative PCR analysis of pediatric
ependymomas identifies novel candidate genes including TPR at 1q25
and CHIBBY at 22q12-q13. Genes Chromosomes Cancer. 47:1005–1022.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fischer V, Brown-Grant DA and Li FQ:
Chibby suppresses growth of human SW480 colon adenocarcinoma cells
through inhibition of β-catenin signaling. J Mol Signal. 7:62012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schuierer MM, Graf E, Takemaru K,
Dietmaier W and Bosserhoff AK: Reduced expression of β-catenin
inhibitor Chibby in colon carcinoma cell lines. World J
Gastroenterol. 12:1529–1535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou CZ, Qiu GQ, Zhang F, He L and Peng
ZH: Loss of heterozygosity on chromosome 1 in sporadic colorectal
carcinoma. World J Gastroenterol. 10:1431–1435. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jenkins D: Histopathology and
cytopathology of cervical cancer. Dis Markers. 23:199–212. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kerns BJ, Jordan PA, Moore MB, Humphrey
PA, Berchuck A, Kohler MF, Bast RC Jr, Iglehart JD and Marks JR:
p53 overexpression in formalin-fixed, paraffin-embedded tissue
detected by immunohistochemistry. J Histochem Cytochem.
40:1047–1051. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giulietti A, Overbergh L, Valckx D,
Decallonne B, Bouillon R and Mathieu C: An overview of real-time
quantitative PCR: Applications to quantify cytokine gene
expression. Methods. 25:386–401. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin HY, Huang CH, Yu TJ, Wu WJ, Yang MC
and Lung FW: p53 codon 72 polymorphism as a progression index for
bladder cancer. Oncol Rep. 27:1193–1199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barker N and Clevers H: Mining the Wnt
pathway for cancer therapeutics. Nat Rev Drug Discov. 5:997–1014.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu B, Crampton SP and Hughes CC: Wnt
signaling induces matrix metalloproteinase expression and regulates
T cell transmigration. Immunity. 26:227–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang K, Li N, Yeung CH, Cooper TG, Liu XX,
Liu J, Wang WT, Li Y, Shi H and Liu FJ: Comparison of gene
expression of the oncogenic Wnt/β-catenin signaling pathway
components in the mouse and human epididymis. Asian J Androl.
17:1006–1011. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jamieson C, Sharma M and Henderson BR: Wnt
signaling from membrane to nucleus: β-catenin caught in a loop. Int
J Biochem Cell Biol. 44:847–850. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shinohara A, Yokoyama Y, Wan X, Takahashi
Y, Mori Y, Takami T, Shimokawa K and Tamaya T: Cytoplasmic/nuclear
expression without mutation of exon 3 of the beta-catenin gene is
frequent in the development of the neoplasm of the uterine cervix.
Gynecol Oncol. 82:450–455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pereira-Suarez AL, Meraz MA, Lizano M,
Estrada-Chávez C, Hernández F, Olivera P, Pérez E, Padilla P, Yaniv
M, Thierry F and García-Carrancá A: Frequent alterations of the
beta-catenin protein in cancer of the uterine cervix. Tumour Biol.
23:45–53. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rodríguez-Sastre MA, González-Maya L,
Delgado R, Lizano M, Tsubaki G, Mohar A and García-Carrancá A:
Abnormal distribution of E-cadherin and beta-catenin in different
histologic types of cancer of the uterine cervix. Gynecol Oncol.
97:330–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Walther A, Johnstone E, Swanton C, Midgley
R, Tomlinson I and Kerr D: Genetic prognostic and predictive
markers in colorectal cancer. Nat Rev Cancer. 9:489–499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jin J, Zhan P, Katoh M, Kobayashi SS, Phan
K, Qian H, Li H, Wang X, Wang X and Song Y; written on behalf of
the AME Lung Cancer Collaborative Group, : Prognostic significance
of β-catenin expression in patients with non-small cell lung
cancer: A meta-analysis. Transl Lung Cancer Res. 6:97–108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang S, Wang Z, Shan J, Yu X, Li L, Lei
R, Lin D, Guan S and Wang X: Nuclear expression and/or reduced
membranous expression of β-catenin correlate with poor prognosis in
colorectal carcinoma: A meta-analysis. Medicine (Baltimore).
95:e55462016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang DP, Li XW and Lang JH: Prognostic
value of β-catenin expression in breast cancer patients: A
meta-analysis. Asian Pac J Cancer Prev. 16:5625–5633. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wu W, Tian Y, Wan H, Ma J, Song Y, Wang Y
and Zhang L: Expression of β-catenin and E- and N-cadherin in human
brainstem gliomas and clinicopathological correlations. Int J
Neurosci. 123:318–323. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Imura J, Ichikawa K, Takeda J and Fujimori
T: Beta-catenin expression as a prognostic indicator in cervical
adenocarcinoma. Int J Mol Med. 8:353–358. 2001.PubMed/NCBI
|
|
45
|
Takemaru K, Yamaguchi S, Lee YS, Zhang Y,
Carthew RW and Moon RT: Chibby, a nuclear beta-catenin-associated
antagonist of the Wnt/Wingless pathway. Nature. 422:905–909. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pestereli HE, Erdogan GG, Karavel S and
Simsek T: Cadherin/catenin expression in squamous lesions of
uterine cervix. Turkish J Cancer. 36:64–68. 2006.
|
|
47
|
García-Tamayo J, Molina J and
Blasco-Olaetxea E: Importance of immunohistochemical studies in the
diagnosis and the prognostic evaluation of cervical intraepithelial
neoplasia and invasive squamous cell carcinoma of the uterine
cervix. Review. Invest Clin. 50:241–250. 2009.(In Spanish).
|
|
48
|
Bahrami A, Hasanzadeh M, ShahidSales S,
Yousefi Z, Kadkhodayan S, Farazestanian M, Mashhad M Joudi, Gharib
M, Hassanian S Mahdi and Avan A: Clinical significance and
prognosis value of Wnt signaling pathway in cervical cancer. J Cell
Biochem. 2017.(Epub ahead of print). View Article : Google Scholar
|
